PURPOSE: The INFLAME study is designed to determine the effect of exercise training on elevated high-sensitivity C-Reactive Protein (CRP) concentrations in initially sedentary women and men. METHODS: INFLAME will recruit 170 healthy, sedentary women and men with elevated CRP (>or=2.0 mg/L) to be randomized to either an exercise group or non-exercise control group. Exercising individuals will participate in four months of supervised aerobic exercise with a total energy expenditure of 16 kcal kg(-1) week(-1) (KKW). Exercise intensity will be 60-80% of maximal oxygen consumption (VO(2) max). OUTCOME: The primary outcome will be changed in plasma CRP concentration. Secondary outcomes include visceral adiposity, the cytokines IL-6 and TNF-alpha, and heart rate variability (HRV) in order to examine potential biological mechanisms whereby exercise might affect CRP concentrations. SUMMARY: INFLAME will help us understand the effects of moderate-to-vigorous exercise on CRP concentrations in sedentary individuals. To our knowledge this will be the largest training study specifically designed to examine the effect of exercise on CRP concentrations. This study has the potential to influence therapeutic applications since CRP measurement is becoming an important clinical measurement in Coronary Heart Disease risk assessment. This study will also contribute to the limited body of literature examining the effect of exercise on the variables of visceral adiposity, cytokines, and heart rate variability.
RCT Entities:
PURPOSE: The INFLAME study is designed to determine the effect of exercise training on elevated high-sensitivity C-Reactive Protein (CRP) concentrations in initially sedentary women and men. METHODS: INFLAME will recruit 170 healthy, sedentary women and men with elevated CRP (>or=2.0 mg/L) to be randomized to either an exercise group or non-exercise control group. Exercising individuals will participate in four months of supervised aerobic exercise with a total energy expenditure of 16 kcal kg(-1) week(-1) (KKW). Exercise intensity will be 60-80% of maximal oxygen consumption (VO(2) max). OUTCOME: The primary outcome will be changed in plasma CRP concentration. Secondary outcomes include visceral adiposity, the cytokines IL-6 and TNF-alpha, and heart rate variability (HRV) in order to examine potential biological mechanisms whereby exercise might affect CRP concentrations. SUMMARY: INFLAME will help us understand the effects of moderate-to-vigorous exercise on CRP concentrations in sedentary individuals. To our knowledge this will be the largest training study specifically designed to examine the effect of exercise on CRP concentrations. This study has the potential to influence therapeutic applications since CRP measurement is becoming an important clinical measurement in Coronary Heart Disease risk assessment. This study will also contribute to the limited body of literature examining the effect of exercise on the variables of visceral adiposity, cytokines, and heart rate variability.
Authors: Timo A Lakka; Hanna-Maaria Lakka; Tuomo Rankinen; Arthur S Leon; D C Rao; James S Skinner; Jack H Wilmore; Claude Bouchard Journal: Eur Heart J Date: 2005-06-29 Impact factor: 29.983
Authors: Michael J LaMonte; J Larry Durstine; Frank G Yanowitz; Tobin Lim; Katrina D DuBose; Paul Davis; Barbara E Ainsworth Journal: Circulation Date: 2002-07-23 Impact factor: 29.690
Authors: Sari Stenholm; Marcello Maggio; Fulvio Lauretani; Stefania Bandinelli; Gian Paolo Ceda; Angelo Di Iorio; Francesco Giallauria; Jack M Guralnik; Luigi Ferrucci Journal: Rejuvenation Res Date: 2010-02 Impact factor: 4.663
Authors: Timothy S Church; Conrad P Earnest; Angela M Thompson; Elisa L Priest; Ruben Q Rodarte; Travis Saunders; Robert Ross; Steven N Blair Journal: Med Sci Sports Exerc Date: 2010-04 Impact factor: 5.411
Authors: Eric S Leifer; Catherine R Mikus; Laura Karavirta; Benjamin D Resnick; William E Kraus; Keijo Häkkinen; Conrad P Earnest; Jerome L Fleg Journal: Med Sci Sports Exerc Date: 2016-01 Impact factor: 5.411
Authors: Benoit J Arsenault; Mélanie Côté; Amélie Cartier; Isabelle Lemieux; Jean-Pierre Després; Robert Ross; Conrad P Earnest; Steven N Blair; Timothy S Church Journal: Atherosclerosis Date: 2009-05-21 Impact factor: 5.162
Authors: Claude Bouchard; Steven N Blair; Timothy S Church; Conrad P Earnest; James M Hagberg; Keijo Häkkinen; Nathan T Jenkins; Laura Karavirta; William E Kraus; Arthur S Leon; D C Rao; Mark A Sarzynski; James S Skinner; Cris A Slentz; Tuomo Rankinen Journal: PLoS One Date: 2012-05-30 Impact factor: 3.240
Authors: Gerardo Moreno; Carol M Mangione; Pin-Chieh Wang; Laura Trejo; Anthony Butch; Chi-Hong Tseng; Catherine A Sarkisian Journal: Curr Gerontol Geriatr Res Date: 2014-06-12
Authors: Matthew P Wahl; Rebecca L Scalzo; Judith G Regensteiner; Jane E B Reusch Journal: Front Endocrinol (Lausanne) Date: 2018-04-18 Impact factor: 5.555